Three Decades of Cannabis Research: What are the Obstacles?
作者信息
Dor Michael
机构信息
Former Senior Medical Cannabis Consultant, Medical Cannabis Unit, Israel Ministry of Health, Jerusalem, Israel. Ariel University.
出版信息
Rambam Maimonides Med J. 2022 Oct 27;13(4):e0028. doi: 10.5041/RMMJ.10486.
Abstract
摘要
相似文献
1
Three Decades of Cannabis Research: What are the Obstacles?
Rambam Maimonides Med J. 2022 Oct 27;13(4):e0028. doi: 10.5041/RMMJ.10486.
2
Attitudes of family physicians towards adolescent cannabis users: a qualitative study in France.
Fam Pract. 2014 Oct;31(5):585-91. doi: 10.1093/fampra/cmu030. Epub 2014 Jun 17.
3
Cannabis and mental health.
Actas Esp Psiquiatr. 2011 May-Jun;39(3):180-90. Epub 2011 May 1.
4
Cannabis in Pain Treatment: Clinical and Research Considerations.
J Pain. 2016 Jun;17(6):654-68. doi: 10.1016/j.jpain.2016.02.007. Epub 2016 Mar 4.
5
Stigma-related barriers to medical cannabis as harm reduction for substance use disorder: Obstacles and opportunities for improvement.
Int J Ment Health Nurs. 2024 Feb;33(1):195-201. doi: 10.1111/inm.13231. Epub 2023 Sep 28.
6
Rationale for cannabis-based interventions in the opioid overdose crisis.
Harm Reduct J. 2017 Aug 18;14(1):58. doi: 10.1186/s12954-017-0183-9.
7
Significance of cannabis use to dental practice.
N Y State Dent J. 2011 Apr;77(3):36-9.
8
The association between lifetime cannabis use and dysthymia across six birth decades.
J Affect Disord. 2018 Jul;234:327-334. doi: 10.1016/j.jad.2018.03.005. Epub 2018 Mar 16.
9
Two Decades of the International Association for Cannabinoid Medicines: 20 Years of Supporting Research and Activities Toward the Medicinal Use of Cannabis and Cannabinoids.
Cannabis Cannabinoid Res. 2021 Apr 15;6(2):82-87. doi: 10.1089/can.2020.0044. eCollection 2021 Apr.
10
Molecular Mechanisms of Cannabis Signaling in the Brain.
Prog Mol Biol Transl Sci. 2016;137:123-47. doi: 10.1016/bs.pmbts.2015.10.002. Epub 2015 Dec 3.
引用本文的文献
1
Subcanopy and Inter-Canopy Supplemental Light Enhances and Standardizes Yields in Medicinal Cannabis ( L.).
Plants (Basel). 2025 May 14;14(10):1469. doi: 10.3390/plants14101469.
本文引用的文献
1
Comparing Sublingual and Inhaled Cannabis Therapies for Low Back Pain: An Observational Open-Label Study.
Rambam Maimonides Med J. 2022 Oct 27;13(4):e0026. doi: 10.5041/RMMJ.10485.
2
[Present Conditions of Marijuana Regulation in USA: Medical and Recreational Use].
Yakugaku Zasshi. 2020;140(2):179-192. doi: 10.1248/yakushi.19-00195-2.
3
Non-medical cannabis in North America: an overview of regulatory approaches.
Public Health. 2020 Jan;178:7-14. doi: 10.1016/j.puhe.2019.08.018. Epub 2019 Oct 7.
4
Predicting Physicians' Intentions to Recommend Medical Cannabis.
J Pain Symptom Manage. 2019 Sep;58(3):400-407. doi: 10.1016/j.jpainsymman.2019.05.010. Epub 2019 May 27.
5
Rhetorical and regulatory boundary-work: The case of medical cannabis policy-making in Israel.
Soc Sci Med. 2018 Nov;217:1-9. doi: 10.1016/j.socscimed.2018.09.047. Epub 2018 Sep 25.
6
Medical cannabis: An oxymoron? Physicians' perceptions of medical cannabis.
Int J Drug Policy. 2018 Jul;57:4-10. doi: 10.1016/j.drugpo.2018.03.025. Epub 2018 Apr 10.
Zotero 插件